This browser is no longer supported

Please switch to a supported browser to continue using this website.
Consider using the latest version of Google Chrome or Microsoft's Edge to view this website.


CSL's 2023 Half Year Financial Results - Announcement Information

We have announced our 2023 Half Year Results for the period ending 31st December 2022.

Announcement Information and Webcast Recording were released on Tuesday, 14th February 2023 (AEDT).

Please click the 'Learn More' link for full information.

COVID-19: A Message from Our CEO

"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited


CSL Mkt Cap:
The Market is currently
Price Delay ~20min
Read More


Annual General Meeting (AGM) Information

CSL's 2022 AGM was held on Wednesday, 12th October 2022.

Learn More

View our interactive online annual report 2022

Introduction to CSL

See how we are driven by our promise.

Learn More

Board and Management

View our Board and Management here.

Learn More

Corporate Governance

View our corporate governance here.

Learn More